Sansure

Established in 2008, as a complete molecular diagnostic solutions developer, manufacturer and provider, Sansure Biotech, Inc. has nearly 10-year experience specializing in molecular diagnostic reagents, instruments and medical service which focuses on clinical diagnosis, public health, research application and food safety. Sansure is a firm practitioner of precision medicine. Under the leadership of Dr. Dai, Sansure has developed complete range of molecular diagnostic products with international standard of excellence on infectious diagnosis, early screening of cancer, prenatal and postnatal disgnosis, etc. Sansure has won second prize of National Science and Technology Progress Award, China Patent Award of Excellence, China Invention and Entrepreneurship Award and other national major innovation awards for its outstanding contributions in Chinese molecular diagnostic market. Sansure devotes to turning the expensive molecular diagnostic to affordable and accessible medical service to everyone needed. With such mission in mind, Sansure’s products have been widely used in more than 1000 hospitals including the class A hospital in China and exported to more than 30 countries including Central and Eastern Europe, Africa, Southeast Asia, etc.